Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joan L Walker
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
503 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- University of California San Diego
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- Colorado Gynecologic Oncology Group
Aurora, Colorado, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- University of Colorado
Denver, Colorado, United States
- Rocky Mountain Gynecologic Oncology Pc
Englewood, Colorado, United States
- Danbury Hospital
Danbury, Connecticut, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut, United States
- Stamford Hospital/bennett Cancer Center
Stamford, Connecticut, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Aug 2009
- Primary completion
- 11 Jan 2016
- Completion
- 11 Jan 2016
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 1,560
- Registry id
- NCT00951496
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.